Publications by authors named "Coreline Burggraaff"

Claim this Profile
I
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.
Matías S Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, Erik van Dijk, Julia Richter, Coreline N Burggraaff

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Gerben J C Zwezerijnen, Jakoba J Eertink, Maria C Ferrández, Sanne E Wiegers, Coreline N Burggraaff

Eur J Nucl Med Mol Imaging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study.
Coreline N Burggraaff, Jakoba J Eertink, Pieternella J Lugtenburg, Otto S Hoekstra, Anne I J Arens

J Nucl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim F-FDG PET in Diffuse Large B-Cell Lymphoma.
Gerben J C Zwezerijnen, Jakoba J Eertink, Coreline N Burggraaff, Sanne E Wiegers, Ekhlas A I N Shaban

J Nucl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Marie José Kersten, Julia Driessen, Josée M Zijlstra, Wouter J Plattel, Franck Morschhauser, Coreline N Burggraaff

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium.
Sally F Barrington, Ben G J C Zwezerijnen, Henrica C W de Vet, Martijn W Heymans, N George Mikhaeel, Coreline N Burggraaff

J Nucl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Martine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, Katerina Bakunina, Rogier Mous

Haematologica· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
Pieternella Johanna Lugtenburg, Peter de Nully Brown, Bronno van der Holt, Francesco A D'Amore, Harry R Koene, Coreline N Burggraaff

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma.
Coreline N Burggraaff, Fareen Rahman, Isabelle Kaßner, Simone Pieplenbosch, Sally F Barrington

Mol Imaging Biol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
Elisabeth Pfaehler, Coreline Burggraaff, Gem Kramer, Josée Zijlstra, Otto S Hoekstra

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative implications of the updated EARL 2019 PET-CT performance standards.
Andres Kaalep, Coreline N Burggraaff, Simone Pieplenbosch, Eline E Verwer, Terez Sera

EJNMMI Phys· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Coreline N Burggraaff, Antoinette de Jong, Otto S Hoekstra, Nikie J Hoetjes, Rutger A J Nievelstein

Eur J Nucl Med Mol Imaging· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver Agreement of Interim and End-of-Treatment F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials.
Coreline N Burggraaff, Alexander C Cornelisse, Otto S Hoekstra, Pieternella J Lugtenburg, Bart De Keizer

J Nucl Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Methods for evaluating medical tests and biomarkers.
Gowri Gopalakrishna, Miranda Langendam, Rob Scholten, Patrick Bossuyt, Mariska Leeflang, Coreline Burggraaff

Diagn Progn Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Josée M Zijlstra, Coreline N Burggraaff, Marie José Kersten, Sally F Barrington,

Haematologica· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis